DOCSLIB.ORG

Kruppel-Like Transcription Factors: Master

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Kruppel-Like Transcription Factors: Master KRUPPEL-LIKE TRANSCRIPTION FACTORS: MASTER REGULATORS OF VASCULAR ENDOTHELIUM by PANJAMAPORN SANGWUNG Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Mukesh K. Jain, MD. Department of Physiology and Biophysics CASE WESTERN RESERVE UNIVERSITY August, 2017 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Panjamaporn Sangwung candidate for the degree of Doctor of Philosophy*. Committee Chair George R. Dubyak, Ph.D. Committee Member Thomas N. Nosek, Ph.D. Committee Member Julian E. Stelzer, Ph.D. Committee Member Jonathan D. Smith, Ph.D. Dissertation Advisor Mukesh K. Jain, M.D. Date of Defense July 6th, 2017 *We also certify that written approval has been obtained for any proprietary material contained therein. DEDICATION This dissertation is dedicated to my family, especially my parents (Boonma and Usanee Saengwang) and my grandparents (Anan and Aonkaew Intana) for their constant source of support and love. TABLE OF CONTENTS LIST OF TABLES………………………………………………………….…………..v LIST OF FIGURES.………………..…………………………..………………………vi ACKNOWLEDGEMENTS………………………… … ……..………….……….….viii LIST OF ABBREVIATIONS………………… …………..…….…………………….xii ABSTRACT……………………………………………….……...……….……..……. 1 CHAPTER 1. SIGNIFICANCE AND INTRODUCTION……………..……………. 3 1.1 Significance ……………………………………………………………….……. 3 1.2 Structure and functional importance of vascular endothelium …..…… 5 Basic structure of blood vessels……………………………………...……... 5 Functional Importance of vascular endothelium…………………………… 7 1.3 Dysfunction of endothelial cells and diseases ………………………..… 14 1.4 Regulation of endothelial function ……………………………………….... 16 Biochemical stimuli……………………………………..………………….… 16 Biomechanical stimuli……………………………………………..…….…… 17 1.5 Kruppel-like factor (KLF) ………………………………………….……..….. 18 Structure of KLFs……………………………………………………………….. 18 Identification and characterization of endothelial KLFs………………....….. 19 KLF2 – Identification and characterization………………..……………..... 19 Role of endothelial KLF2…………………………………….………….…... 21 Regulation of endothelial KLF2………………………………………….…. 25 KLF4 – Identification and Characterization……………………………….. 30 i Role of endothelial KLF4………………………….…………………….…... 31 Regulation of endothelial KLF4…………………………………….….…… 32 KLF6 – Identification, characterization, and functions………………....... 33 1.6 Endothelial hemoglobin …………………………………..……………….... 35 Functional importance of hemoglobin …………………………………..….... 35 Hemoglobin and disorders…………………………………………………..… 36 Structure of hemoglobin ……………………………………………….……..... 37 Regulation of hemoglobin………………………………………………….…... 37 Hemoglobin in non-erythroid cells…………………………………………..… 38 CHAPTER 2. KLF2 AND KLF4 CONTROL ENDOTHELIAL IDENTITY AND VASCULAR INTEGRITY…..…………………………..………………………....... 41 2.1 Abstract………..…………………………………………………….……….….. 41 2.2 Introduction………..…………………………………………………..……...… 42 2.3 Materials and methods…………………………………………….………...... 44 2.4 Results…….……………………………………………………...…..………..... 52 Endothelial-specific Klf2 and Klf4 deletion leads to rapid death of adult Mice..………………………………………………………………………...... 52 Endothelial-specific deletion of Klf2 and Klf4 leads to vascular leak and systemic coagulopathy……………………………………………........ 59 Endothelial-specific Klf2 and Klf4 deletion results in profound alterations in the EC transcriptome…………………………….…...……… 67 2.5 Discussion and conclusion...………………………………………...……… 69 ii 2.6 Author contributions……...…………………………………………...……… 73 2.7 Acknowledgments…………...………………………………………...………. 73 CHAPTER 3. REGULATION OF ENDOTHELIAL HEMOGLOBIN ALPHA EXPRESSION BY KRUPPEL-LIKE FACTORS……………..…………………... 74 3.1 Abstract………..………………………………………………...………...……. 74 3.2 Introduction………..………………………………………………...……..…… 75 3.3 Materials and methods………………………………………………..….…… 77 3.4 Results…….…………………………………………………………………..…. 85 KLF2 and KLF4 induce HBA expression in the endothelium…………………… 85 The transactivation of the human hemoglobin alpha gene promoter in ECs by KLF2/KLF4………………………………………………………... 93 Direct binding of KLF4 to the endogenous hemoglobin alpha promoter in the EC………………………………………………….............. 98 3.5 Discussion…….…………………………………………………..…………… 100 3.6 Conclusion…….………………………...…………………………..………… 102 3.7 Acknowledgment……………………...…………..………………..………… 102 CHAPTER 4. DISCUSSION AND SUMMARY STATEMENTS OF THE THESIS PROJECTS …………………………………………………………. 103 4.1 Discussion …….………………………...…………………………..……….... 103 4.2 Summary statements of the thesis projects…..…..…………....…..….... 106 iii CHAPTER 5. FUTURE DIRECTIONS…….………………......................…...... 107 BIBLIOGRAPHY.…………………....…………………………...……………….... 109 iv LIST OF TABLES Table 2.1 Primer sequences for qPCR (TaqMan) analysis………………….….. 46 Table 2.2 Differentially expressed genes (q<0.05) in the Hallmark coagulation pathway (EC-DKO vs CRE) at day 6 post-tamoxifen……… 72 Table 3.1 Primer sequences for qPCR (TaqMan) analysis……………….…….. 79 Table 3.2 The HBA promoter mutagenic oligonucleotide primers (5’-3’)………. 83 Table 3.3 Identified peptides of HBA protein in the MEJ of KLF4 overexpressing HCAECs using LC-MS/MS………………..…….……….. 92 v LIST OF FIGURES Figure 1.1 Basic structure of normal artery…………………………………………. 5 Figure 1.2 Schematic representation of both tight and adherens junctions in ECs…………………………………………………...…............... 9 Figure 1.3 The TM/protein C/protein S anticoagulation system….……………… 11 Figure 1.4 NO production by eNOS………………………………………….…….. 13 Figure 1.5 A schematic representation of common structure and functional domains for Krüppel-like factors (KLFs)………………………... 18 Figure 1.6 Human hemoglobin genes located on chromosome 11and 16 ….… 38 Figure 1.7 Possible mechanism of NO control at the MEJ………………….…… 40 Figure 2.1 Expression of Klf2, Klf4, and their targets in primary cardiac microvascular EC……………………………….………………………….…. 54 Figure 2.2 Endothelial-specific Klf2 and Klf4 deletion leads to rapid death of adult mice……………….……………………….….……………….. 55 Figure 2.3 Electrocardiogram (EKG) recording………….……………….……….. 56 Figure 2.4 Echocardiographic analysis at day 6 after tamoxifen administration……………………….……………..…………………….……. 57 Figure 2.5 Gross post-mortem examination in EC-Klf2-KO and EC-Klf4-KO mice…………………………………..……………..…………… 58 Figure 2.6 Endothelial-specific deletion of Klf2 and Klf4 leads to vascular leak and systemic coagulopathy………………..….…...………… 62 Figure 2.7 Endothelial-specific deletion of Klf2 and Klf4 results in vascular leak…………………..……………………..…………..…….……… 64 vi Figure 2.8 Representative electron microscopic (EM) images of brain indicate degeneration of EC and extravascular erythrocytes in the EC-DKO mice at day 6 post-tamoxifen……………………..………….. 65 Figure 2.9 Expression of F3, Serpine1, and F2rl3 mRNA in primary cardiac microvascular EC at day 6 post-tamoxifen……………...………… 66 Figure 2.10 Endothelial-specific Klf2 and Klf4 deletion results in profound alterations in the EC transcriptome……………………………………….… 68 Figure 3.1 Hemoglobin alpha mRNA expression in the EC by KLF2/KLF4…… 87 Figure 3.2 Expression of KLF2 or KLF4 mRNA in ECs………………………….. 88 Figure 3.3 KLF2/KLF4-mediated hemoglobin alpha protein expression in the EC cultured alone on a petri dish…………………………................ 89 Figure 3.4 Hemoglobin alpha protein expression in the EC by KLF2/KLF4…... 90 Figure 3.5 KLF2/KLF4-mediated hemoglobin alpha protein expression in the EC and the MEJ obtained from the co-cultured model…………….. 91 Figure 3.6 KLF2/KLF4 mediate a transactivation of the HBA promoter………... 95 Figure 3.7 KLF2/KLF4 fail to mediate a transactivation of the mutant HBA promoter………………………………………………….……………… 96 Figure 3.8 Critical KLF-binding sites on the HBA promoter……………………... 97 Figure 3.9 Direct binding of KLF4 on the HBA promoter in the EC…………...... 99 vii ACKNOWLEDGEMENTS I would like to express my wholehearted thanks to all those who helped me to make my PhD study and dissertation work a success. This dissertation would not have been possible without help of many people. First and foremost, I would like to express my grateful thanks to my mentor, Dr. Mukesh Jain, for giving me the opportunity to join the lab and for giving me mental and technical advice on my professional and personal life. Dr.Jain is one of the best mentors I have ever had in my life. Dr.Jain provided leadership development, useful guidance, tutelage, consultation, and feedback to me. He also provided me with opportunity to explore research, full material supports, and expert. He connected me to resources to ensure progress of the projects. He motivated, supported, and challenged me to push myself beyond the limits to achieve the goals and success in my profession. Dr.Jain is an outstanding physician scientist, a great speaker, and creative writer. I have learned a tremendous amount from him. I am pleased to acknowledge and thank my dissertation committees (Drs. George Dubyak, Jonathan Smith, Thomas Nosek, and Julian Stelzer). I met my dissertation committees at least once a year. My committees helped me directing my research and troubleshooting problems. Dr. Dubyak is one of the best teachers I have ever met. He has tremendous amount of knowledge in vascular biology and cell signaling. He was always available for me when needed. Dr. Dubyak provided guidance to access to internal and external resources, and viii served as troubleshooters. He helped me plan a graduation timeline and made sure that things moved along. Dr. Smith encouraged me to think critically by challenging me with logical questions, and to become better problem solvers. He has massive amount
Load more

Recommended publications
  • The Role of PU.1 and GATA-1 Transcription Factors During Normal and Leukemogenic Hematopoiesis
    Leukemia (2010) 24, 1249–1257 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 www.nature.com/leu REVIEW The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis P Burda1, P Laslo2 and T Stopka1,3 1Department of Pathophysiology and Center of Experimental Hematology, First Faculty of Medicine, Charles University, Prague, Czech Republic; 2Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leads, St James’s University Hospital, Leeds, UK and 31st Department of Medicine-Hematology, General University Hospital, Prague, Czech Republic Hematopoiesis is coordinated by a complex regulatory network Additional domains include an N-terminal acidic domain and a of transcription factors and among them PU.1 (Spi1, Sfpi1) glutamine-rich domain, both involved in transcriptional activa- represents a key molecule. This review summarizes the tion, as well as a PEST domain involved in protein–protein indispensable requirement of PU.1 during hematopoietic cell fate decisions and how the function of PU.1 can be modulated interactions. PU.1 protein can be modified post-translationally by protein–protein interactions with additional factors. The by phosporylation at serines 41 (N-terminal acidic domain) and mutual negative regulation between PU.1 and GATA-1 is 142 and 148 (PEST domain), which results in augmented detailed within the context of normal and leukemogenic activity. hematopoiesis and the concept of ‘differentiation therapy’ to The PU.1 protein can physically interact with a variety of restore normal cellular differentiation of leukemic cells is regulatory factors including (i) general transcription factors discussed. Leukemia (2010) 24, 1249–1257; doi:10.1038/leu.2010.104; (TFIID, TBP), (ii) early hematopoietic transcription factors published online 3 June 2010 (GATA-2 and Runx-1), (iii) erythroid factor (GATA-1) and (iv) Keywords: PU.1; leukemia differentiation; GATA-1; chromatin; non-erythroid factors (C/EBPa, C/EBPb, IRF4/8 and c-Jun).
    [Show full text]
  • KLF2 Induced
    UvA-DARE (Digital Academic Repository) The transcription factor KLF2 in vascular biology Boon, R.A. Publication date 2008 Link to publication Citation for published version (APA): Boon, R. A. (2008). The transcription factor KLF2 in vascular biology. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:23 Sep 2021 Supplementary data: Genes induced by KLF2 Dekker et al. LocusLink Accession Gene Sequence Description Fold p-value ID number symbol change (FDR) 6654 AK022099 SOS1 cDNA FLJ12037 fis, clone HEMBB1001921. 100.00 5.9E-09 56999 AF086069 ADAMTS9 full length insert cDNA clone YZ35C05. 100.00 1.2E-09 6672 AF085934 SP100 full length insert cDNA clone YR57D07. 100.00 6.7E-13 9031 AF132602 BAZ1B Williams Syndrome critical region WS25 mRNA, partial sequence.
    [Show full text]
  • 5045.Full.Pdf
    IFN Consensus Sequence Binding Protein (Icsbp) Is Critical for Eosinophil Development This information is current as Maja Milanovic, Grzegorz Terszowski, Daniela Struck, of September 28, 2021. Oliver Liesenfeld and Dirk Carstanjen J Immunol 2008; 181:5045-5053; ; doi: 10.4049/jimmunol.181.7.5045 http://www.jimmunol.org/content/181/7/5045 Downloaded from References This article cites 47 articles, 33 of which you can access for free at: http://www.jimmunol.org/content/181/7/5045.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology IFN Consensus Sequence Binding Protein (Icsbp) Is Critical for Eosinophil Development1 Maja Milanovic,2* Grzegorz Terszowski,2† Daniela Struck,2‡ Oliver Liesenfeld,‡ and Dirk Carstanjen3* IFN consensus sequence binding protein (Icsbp) (IFN response factor-8) is a hematopoietic transcription factor with dual functions in myelopoiesis and immunity.
    [Show full text]
  • Transcriptome Analysis of Gravitational Effects on Mouse Skeletal Muscles Under Microgravity and Artificial 1 G Onboard Environm
    www.nature.com/scientificreports OPEN Transcriptome analysis of gravitational efects on mouse skeletal muscles under microgravity and artifcial 1 g onboard environment Risa Okada1,2, Shin‑ichiro Fujita3,4, Riku Suzuki5,6, Takuto Hayashi3,5, Hirona Tsubouchi5, Chihiro Kato5,7, Shunya Sadaki5, Maho Kanai5,6, Sayaka Fuseya3,5, Yuri Inoue3,5, Hyojung Jeon5, Michito Hamada5, Akihiro Kuno5,6, Akiko Ishii8, Akira Tamaoka8, Jun Tanihata9, Naoki Ito10, Dai Shiba1,2, Masaki Shirakawa1,2, Masafumi Muratani1,4, Takashi Kudo1,5* & Satoru Takahashi1,5* Spacefight causes a decrease in skeletal muscle mass and strength. We set two murine experimental groups in orbit for 35 days aboard the International Space Station, under artifcial earth‑gravity (artifcial 1 g; AG) and microgravity (μg; MG), to investigate whether artifcial 1 g exposure prevents muscle atrophy at the molecular level. Our main fndings indicated that AG onboard environment prevented changes under microgravity in soleus muscle not only in muscle mass and fber type composition but also in the alteration of gene expression profles. In particular, transcriptome analysis suggested that AG condition could prevent the alterations of some atrophy‑related genes. We further screened novel candidate genes to reveal the muscle atrophy mechanism from these gene expression profles. We suggest the potential role of Cacng1 in the atrophy of myotubes using in vitro and in vivo gene transductions. This critical project may accelerate the elucidation of muscle atrophy mechanisms. Gravity is the most constant factor afecting the entire process of evolution of organisms on Earth. As adapting to a changing environment is key for any organism’s survival, the constant mechanical stimulus of gravitational force has been shared by all organisms on Earth through evolution 1.
    [Show full text]
  • Angiogenic Patterning by STEEL, an Endothelial-Enriched Long
    Angiogenic patterning by STEEL, an endothelial- enriched long noncoding RNA H. S. Jeffrey Mana,b, Aravin N. Sukumara,b, Gabrielle C. Lamc,d, Paul J. Turgeonb,e, Matthew S. Yanb,f, Kyung Ha Kub,e, Michelle K. Dubinskya,b, J. J. David Hob,f, Jenny Jing Wangb,e, Sunit Dasg,h, Nora Mitchelli, Peter Oettgeni, Michael V. Seftonc,d,j, and Philip A. Marsdena,b,e,f,1 aInstitute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada; bKeenan Research Centre for Biomedical Science in the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, ON M5B 1T8, Canada; cDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 3E2, Canada; dInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; eDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada; fDepartment of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; gArthur and Sonia Labatt Brain Tumour Research Institute, Hospital for SickKids, University of Toronto, Toronto, ON M5G 1X8, Canada; hDivision of Neurosurgery and Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, University of Toronto, Toronto, ON M5B 1W8, Canada; iDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115; and jDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada Edited by Napoleone Ferrara, University of California, San Diego, La Jolla, CA, and approved January 24, 2018 (received for review August 28, 2017) Endothelial cell (EC)-enriched protein coding genes, such as endothelial formation in vitro and blood vessel formation in vivo.
    [Show full text]
  • Expression of Wilms Tumor 1 Gene Distinguishes Vascular Malformations from Proliferative Endothelial Lesions
    OBSERVATION Expression of Wilms Tumor 1 Gene Distinguishes Vascular Malformations From Proliferative Endothelial Lesions Leslie P. Lawley, MD; Francesca Cerimele, MD, PhD; Sharon W. Weiss, MD; Paula North, MD; Cynthia Cohen, MD; Harry P. W. Kozakewich, MD; John B. Mulliken, MD; Jack L. Arbiser, MD, PhD Background: Vascular malformations and hemangio- Observations: The biochemical differences between mas, which are endothelial lesions of childhood, may re- hemangiomas, which involute, and vascular malforma- sult in considerable morbidity because they can cause dis- tions, which do not involute, are not well understood. comfort and functional impairment and have a negative We found that the transcription factor encoded by the affect on the patient’s appearance. Although vascular mal- Wilms tumor 1 (WT1) gene is expressed in the endothe- formations may initially appear very similar to heman- lium of hemangiomas but not in vascular malforma- giomas, they have distinct clinical courses. Infantile hem- tions. angiomas progress through 3 stages: proliferative, involuting, and involuted. The proliferative phase is char- Conclusions: Defects in WT1 signaling may underlie the acterized by clinical growth. Once hemangiomas reach inability of malformation endothelial cells to undergo their maximum size, they begin to regress or involute. physiologic apoptosis and remodeling. The availability Histologically, this stage is characterized by endothelial of WT1 staining in hospital laboratories may allow the apoptosis. Finally, the involuted stage of the heman- clinician to distinguish hemangiomas from vascular mal- gioma occurs when the original lesion is replaced by a formations and thus to give appropriate therapy to the connective tissue remnant. In contrast to hemangio- patient. mas, vascular malformations do not involute but con- tinue to enlarge as the patient grows.
    [Show full text]
  • Letters to the Editor
    LETTERS TO THE EDITOR The significant upregulation of Gata1 and EpoR mRNA Mice over-expressing human erythropoietin expression in hEPO over-expressing tg6 mice was con - indicate that erythropoietin enhances expression firmed by analyzing the spleen as a major source of of its receptor via up-regulated Gata1 and Tal1 hematopoiesis (Figure 2A and B). To further dissect the complexity of changes in the transcriptional network, the analysis of Myb mRNA expression served as marker for The development of medullary hematopoiesis is char - adult definitive erythroblasts, 10 showing significantly acterized by a specific expression profile of hematopoiet - ic transcription factors, including GATA transcription fac - tors. At mid-gestation, when hematopoiesis is newly A GATA 1 2 established in the bone marrow of human fetuses, initial - wt ly high GATA2 expression becomes subsequently down- regulated, while GATA1 expression increases in parallel. 1 1.5 Both transcription factors bind to overlapping sets of tg6 hematopoietic downstream target genes, often at distinct 1 sites, to regulate the balance between proliferation and differentiation. Chromatin occupancy by GATA1 and 0.5 GATA2 can change in the course of hematopoietic differ - entiation, leading to the so-called GATA switch. 2 Thus, a 0 n d7 d21 d49 i spatio-temporal regulation of GATA1 or GATA2 activities t c is required within lineage-specific differentiation. During a - erythroid differentiation GATA1 expression peaks at the b B GATA 2 3 o level of colony-forming units (CFU-E), where erythro - t 2 e poietin (Epo) exerts most specifically its effects, but v i t blocks terminal maturation if constitutively over- a 1.5 l 4 e expressed.
    [Show full text]
  • Inhibition of Adipocyte Differentiation by Rorα
    FEBS Letters 583 (2009) 2031–2036 journal homepage: www.FEBSLetters.org Inhibition of adipocyte differentiation by RORa Hélène Duez a,b,c,1, Christian Duhem a,b,c,1, Saara Laitinen a,b,c, Prashant S. Patole a,b,c, Mouaadh Abdelkarim a,b,c, Brigitte Bois-Joyeux d, Jean-Louis Danan d, Bart Staels a,b,c,* a Institut Pasteur de Lille, Département d’Athérosclérose, Lille F-59019, France b INSERM UMR 545, Lille F-59019, France c Université Lille Nord de France, Faculté des Sciences Pharmaceutiques et Biologiques et Faculté de Médecine, Lille F-59006, France d Centre National de la Recherche Scientifique FRE3210, Faculté de Médecine René Descartes Paris 5, 75015 Paris, France article info abstract Article history: Here we show that gene expression of the nuclear receptor RORa is induced during adipogenesis, Received 8 April 2009 with RORa4 being the most abundantly expressed isoform in human and murine adipose tissue. Revised 27 April 2009 Over-expression of RORa4 in 3T3-L1 cells impairs adipogenesis as shown by the decreased expres- Accepted 8 May 2009 sion of adipogenic markers and lipid accumulation, accompanied by decreased free fatty acid and Available online 18 May 2009 glucose uptake. By contrast, mouse embryonic fibroblasts from staggerer mice, which carry a muta- Edited by Robert Barouki tion in the RORa gene, differentiate more efficiently into mature adipocytes compared to wild-type cells, a phenotype which is reversed by ectopic RORa4 restoration. Ó 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. Keywords: Adipogenesis RORa Nuclear receptors RAR-related orphan receptors (RORs) 1.
    [Show full text]
  • Enhancer of WT1 Gene Is Essential for Its Transcription in Acute Leukemia and Solid Tumor Cell Lines
    Leukemia (2009) 23, 1270–1277 & 2009 Macmillan Publishers Limited All rights reserved 0887-6924/09 $32.00 www.nature.com/leu ORIGINAL ARTICLE GATA-1 and GATA-2 binding to 30 enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines A Furuhata1, M Murakami1, H Ito1, S Gao1, K Yoshida1, S Sobue2, R Kikuchi3, T Iwasaki3, A Takagi1, T Kojima1, M Suzuki4, A Abe5, T Naoe5 and T Murate1 1Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya, Japan; 2Department of Pathology, College of Life and Health Sciences, Chubu University, Kasugai, Japan; 3Department of Laboratory Medicine, Nagoya University School of Medicine, Nagoya, Japan; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya, Japan and 5Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Although oncogenic functions and the clinical significance of WT1 have been well documented, its gene-expression mecha- Wilms tumor 1 (WT1) have been extensively studied in acute nism remains undetermined. leukemia, the regulatory mechanism of its transcription still 13 remains to be determined. We found a significant correlation In the promoter analysis of WT1 gene, Cohen et al. reported among the amounts of WT1, GATA-1 and GATA-2 mRNAs from the importance of Sp1 for mRNA expression, although the leukemia and solid tumor cell lines. Overexpression and small promoter region may not determine the tissue-specific manner interfering RNA (siRNA) transfection experiments of GATA-1 of WT1 expression.13,14 Regarding this point, the 30 enhancer and GATA-2 showed that these GATA transcription factors located 450 kb downstream of the promoter was identified as could induce WT1 expression.
    [Show full text]
  • Regulation of T Follicular Helper Cells by ICOS
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No. 26 Editorial Regulation of T follicular helper cells by ICOS Andreas Hutloff T follicular helper (TFH) cells are gatekeepers of the (OPN-i), which facilitates nuclear translocation [3]. In the humoral immune response. Without help from this CD4+ nucleus, OPN-i dimerizes with Bcl-6 and protects it from T cell subset, B cells cannot differentiate into high-affinity proteasomal degradation. However, this OPN-i and the memory B cells and antibody-producing long-lived plasma above Klf2 pathway do act at different times. Upon ICOS cells which are the basis of protective immune responses. signaling blockade, Klf2 is upregulated within a few hours At the same time, dysregulated TFH cell responses are and TFH cells lose their typical homing receptor pattern in causative for many autoimmune disorders (reviewed in less than 24 hours [6]. In contrast, complete degradation [1]). The inducible T cell costimulator ICOS, which is of Bcl-6 takes several days [3, 6]. Therefore, the ICOS - structurally and functionally related to CD28, has been Klf2 axis first leads to emigration of TFH cells out of the known for many years as an important regulator of TFH B cell follicle (and thereby to a loss of function), whereas cells. ICOS knock-out mice as well as ICOS-deficient the osteopontin pathway acts as a second strike pathway patients have only few TFH cells and very small germinal eliminating the lineage-defining transcription factor Bcl-6. centers upon immunization, which results in severely Another important finding especially for potential compromised antigen-specific immunoglobulin levels therapeutic applications is that ICOS and the structurally and the phenotype of common variable immunodeficiency related CD28 molecule act in different phases of TFH cell in humans (reviewed in [2]).
    [Show full text]
  • Beta Cell Adaptation to Pregnancy Requires Prolactin Action on Both
    www.nature.com/scientificreports OPEN Beta cell adaptation to pregnancy requires prolactin action on both beta and non‑beta cells Vipul Shrivastava1, Megan Lee1, Daniel Lee1, Marle Pretorius1, Bethany Radford1, Guneet Makkar1 & Carol Huang1,2,3* Pancreatic islets adapt to insulin resistance of pregnancy by up regulating β‑cell mass and increasing insulin secretion. Previously, using a transgenic mouse with global, heterozygous deletion of prolactin receptor (Prlr+/−), we found Prlr signaling is important for this adaptation. However, since Prlr is expressed in tissues outside of islets as well as within islets and prolactin signaling afects β‑cell development, to understand β‑cell‑specifc efect of prolactin signaling in pregnancy, we generated a transgenic mouse with an inducible conditional deletion of Prlr from β‑cells. Here, we found that β‑cell‑specifc Prlr reduction in adult mice led to elevated blood glucose, lowed β‑cell mass and blunted in vivo glucose‑stimulated insulin secretion during pregnancy. When we compared gene expression profle of islets from transgenic mice with global (Prlr+/−) versus β‑cell‑specifc Prlr reduction (βPrlR+/−), we found 95 diferentially expressed gene, most of them down regulated in the Prlr+/− mice in comparison to the βPrlR+/− mice, and many of these genes regulate apoptosis, synaptic vesicle function and neuronal development. Importantly, we found that islets from pregnant Prlr+/− mice are more vulnerable to glucolipotoxicity‑induced apoptosis than islets from pregnant βPrlR+/− mice. These observations suggest that down regulation of prolactin action during pregnancy in non‑β‑cells secondarily and negatively afect β‑cell gene expression, and increased β‑cell susceptibility to external insults.
    [Show full text]
  • GATA1 Gene GATA Binding Protein 1
    GATA1 gene GATA binding protein 1 Normal Function The GATA1 gene provides instructions for making a protein that attaches (binds) to specific regions of DNA and helps control the activity of many other genes. On the basis of this action, the GATA1 protein is known as a transcription factor. The GATA1 protein is involved in the specialization (differentiation) of immature blood cells. To function properly, these immature cells must differentiate into specific types of mature blood cells. By binding to DNA and interacting with other proteins, the GATA1 protein regulates the growth and division (proliferation) of immature red blood cells and platelet-precursor cells (megakaryocytes) to facilitate their differentiation. Red blood cells help carry oxygen to various tissues throughout the body and platelets aid in blood clotting. The GATA1 protein is also important for the maturation of several types of white blood cells that help fight infection, including eosinophils, mast cells, and dendritic cells. Two versions of the GATA1 protein are produced from the GATA1 gene: a regular length protein and a shorter version called GATA1s. The GATA1s protein lacks a specific region called the transactivation domain. Although the specific function of this region is unclear, researchers believe that it interacts with other proteins to modify GATA1 protein function. Health Conditions Related to Genetic Changes Dyserythropoietic anemia and thrombocytopenia At least eight different mutations in the GATA1 gene have been found to cause dyserythropoietic anemia and thrombocytopenia. Most of these mutations change a single protein building block (amino acid) in the GATA1 protein. GATA1 gene mutations disrupt the protein's ability to bind with DNA or interact with other proteins.
    [Show full text]